Paysign, Inc. to Host Yearend Earnings Call
April 03 2020 - 2:15PM
Business Wire
Paysign, Inc. (NASDAQ: PAYS), a vertically integrated provider
of innovative prepaid card programs, digital banking and processing
services for corporate, consumer and government applications, will
discuss 2019 earnings at 12:00 PM Eastern Time on Monday, April 6,
2020.
Participant details are as follows: US dial-in:
877-407-2988 Int’l dial-in: 201-389-0923 Webcast:
Click Here Replay: Dial-in:
877-660-6853 / 201-612-7415 Conf ID #:
13696176
To register as a financial professional in order to ask
questions during the call, please email ir@paysign.com by 5:00 PM
Eastern Time on Sunday, April 5, 2020.
About Paysign, Inc.
Paysign, Inc (NASDAQ: PAYS) is an experienced and trusted
prepaid debit card payment solutions provider as well as an
integrated payment processor that has managed millions of prepaid
debit cards in its portfolio. Paysign conceptualizes, develops and
manages payment solutions, prepaid card programs, and customized
payment services. Paysign’s corporate incentive prepaid cards are
changing the way corporations reward, motivate, and engage their
current and potential customers, employees, and agents. Paysign’s
customizable solutions offer significant cost savings while
improving brand recognition and customer loyalty. For over 15 years
healthcare companies, major pharmaceutical companies,
multinationals, prestigious universities, and social media
companies have relied on Paysign to provide state of the art
prepaid payment programs tailored to their unique
requirements.Paysign is a registered trademark of Paysign, Inc. in
the United States and other countries. For more information visit
us at paysign.com, or follow us on Facebook, Twitter, and
LinkedIn.
Forward-Looking Statements
Certain statements contained in this press release may be deemed
to be forward-looking statements under federal securities laws, and
the company intends that such forward-looking statements be subject
to the safe-harbor created thereby. All statements, other than
statements of fact, included in this release, are forward-looking
statements. Such forward-looking statements include, among others,
the company’s belief in its ability to ensure continuity during the
COVID-19 outbreak; that the company remains enthusiastic about the
long term trajectory of the company; that the company expects
continued growth in both revenue and net income in 2020; that the
company does not anticipate a decline in the demand for
pharmaceutical patient affordability products; that the company
expects to see continued revenue and earnings growth; and that the
company expects similar gross margins to 2019. We caution that
these statements are qualified by important risks, uncertainties,
and other factors that could cause actual results to differ
materially from those reflected by such forward-looking statements.
Such factors include, among others, the inability to continue our
current growth rate in future periods; identified material
weaknesses in our internal control over financial reporting which
could, if not remediated, adversely affect our ability to report
our financial condition and results of operations in a timely and
accurate manner; that a downturn in the economy, including as a
result of COVID-19, could reduce our customer base and demand for
our products and services, which could have an adverse effect on
our business, financial condition, profitability, and cash flows;
operating in a highly regulated environment; failure by us or
business partners to comply with applicable laws and regulations;
changes in the laws, regulations, credit card association rules or
other industry standards affecting our business; that a data
security breach could expose us to liability and protracted and
costly litigation; and other risk factors set forth in our Form
10-K for the year ended December 31, 2019. Except to the extent
required by federal securities laws, the company undertakes no
obligation to publicly update or revise any statements in this
release, whether as a result of new information, future events, or
otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200403005464/en/
Paysign, Inc. Jim McCroy, 702-749-7269 Investor Relations
ir@paysign.com http://www.paysign.com
Paysign (NASDAQ:PAYS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Paysign (NASDAQ:PAYS)
Historical Stock Chart
From Apr 2023 to Apr 2024